Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Percheron Therapeutics ( (AU:PER) ) has shared an announcement.
Percheron Therapeutics, a company involved in the biotechnology sector, recently responded to an inquiry from the Australian Securities Exchange regarding a director’s trading activities. The company clarified its compliance with disclosure obligations, detailing the approval process for Dr. James Garner’s share transactions. The misunderstanding about trading periods was attributed to an outdated understanding of the company’s Securities Trading Policy, which had been updated in late 2024.
More about Percheron Therapeutics
Average Trading Volume: 10,000
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $6.8M
See more data about PER stock on TipRanks’ Stock Analysis page.